Document is current
Any future updates will be listed below
-
Authors
Rahal, Zahraa
El Darzi, Roy https://orcid.org/0009-0007-7638-8979
Moghaddam, Seyed Javad https://orcid.org/0000-0002-5350-307X
Cascone, Tina
Kadara, Humam https://orcid.org/0000-0003-2976-9115
- License Information
-
More Information
Article History
Accepted: 16 April 2025
First Online: 16 May 2025
Competing interests
: S.J.M. receives funding from Arrowhead Pharma and Boehringer Ingelheim outside the scope of the submitted work. T.C. reports speaker fees and/or honoraria (including travel and meeting expenses) from ASCO Post, AstraZeneca, Bio Ascend, Bristol Myers Squibb, Clinical Care Options, IDEOlogy Health, Medical Educator Consortium, Medscape, OncLive, PEAK Medicals, PeerView, Physicians’ Education Resource and Targeted Oncology; fees for advisory or consulting roles (including travel and meeting expenses) from AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Genentech, Merck, oNKo-innate, Pfizer, RAPT Therapeutics and Regeneron; and institutional research funding from AstraZeneca and Bristol Myers Squibb. H.K. reports funding from Johnson and Johnson outside the scope of the submitted work.
